It`s a very intresting partner, the Cann Global Ltd team have found ! http://pharmocann.com/production/ They are established and have 9 years as a business in the Cannabis industry. Given they have the right resources, experience and knowledge - I reckon we are lucky to partner up with them. When you read about Pharmocann on the website, one have to be impressed - these guys are the real deal.
Highlights • Medcan will manufacture Pharmocann’s range of products under a 50/50 JV for Australian and International distribution • Medcan and Pharmocann will collaborate on clinical trials in both Israel and Australia • Pharmocann will provide IP, standard operating procedures, recipes and manufacturing techniques including existing Israeli clinical trial data in respect of its products • Medcan will be responsible for the manufacturing facility, required Australian licences and the raw cannabis material required for product manufacture and international export Background –
Pharmocann Pharmocann Ltd is a company registered in Israel which develops and grows medicinal cannabis in GAP standard greenhouses, and supplies, under license, medical cannabis products throughout Israel. For over 10 years Pharmocann has supplied more than 4500 registered patients medicinal cannabis dried flower, oils and ointments. Pharmocann has developed a range of medicinal cannabis products and is in the process of conducting human clinical trials in Israel on a number of these products. Medcan Australia’s CEO, Craig Cochran, commented “We are excited to have finally entered into this MOU with Pharmocann after being in detailed discussions with them since early 2017. Pharmocann are one of the top Israeli medicinal cannabis companies and have developed a unique range of products which are showing extraordinary results in clinical trials" (full document text from 18 of october) 2019 will be a dynamic year for this tiny pennystock.
Trade starts friday the 21 of december - Cann Global is a go !
Highlights • Medcan will manufacture Pharmocann’s range of products under a 50/50 JV for Australian and International distribution • Medcan and Pharmocann will collaborate on clinical trials in both Israel and Australia • Pharmocann will provide IP, standard operating procedures, recipes and manufacturing techniques including existing Israeli clinical trial data in respect of its products • Medcan will be responsible for the manufacturing facility, required Australian licences and the raw cannabis material required for product manufacture and international export Background –
Pharmocann Pharmocann Ltd is a company registered in Israel which develops and grows medicinal cannabis in GAP standard greenhouses, and supplies, under license, medical cannabis products throughout Israel. For over 10 years Pharmocann has supplied more than 4500 registered patients medicinal cannabis dried flower, oils and ointments. Pharmocann has developed a range of medicinal cannabis products and is in the process of conducting human clinical trials in Israel on a number of these products. Medcan Australia’s CEO, Craig Cochran, commented “We are excited to have finally entered into this MOU with Pharmocann after being in detailed discussions with them since early 2017. Pharmocann are one of the top Israeli medicinal cannabis companies and have developed a unique range of products which are showing extraordinary results in clinical trials" (full document text from 18 of october) 2019 will be a dynamic year for this tiny pennystock.
Trade starts friday the 21 of december - Cann Global is a go !
Robert
